Trial · NCT07882043
Registered outcomes37
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 37
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | GI symptoms | Visit 1 (baseline) | Visual analogue scale (VAS) score for gastrointestinal (GI) symptoms |
| Primary | GI symptoms | Visit 2 (5±1 days from baseline) | Visual analogue scale (VAS) score for gastrointestinal (GI) symptoms |
| Primary | GI symptoms | Visit 3 (90±3 days from baseline) | Visual analogue scale (VAS) score for gastrointestinal (GI) symptoms |
| Primary | GI symptoms | Visit 4 (180±3 days from baseline) | Visual analogue scale (VAS) score for gastrointestinal (GI) symptoms |
| Primary | IgG | Visit 1 (baseline) | Blood IgG levels |
| Primary | IgG | Visit 4 (180±3 days from baseline) | Blood IgG levels |
| Secondary | hsCRP | Visit 1 (baseline) | Blood hsCRP levels |
| Secondary | hsCRP | Visit 4 (180±3 days from baseline) | Blood hsCRP levels |
| Secondary | IL-4 | Visit 1 (baseline) | Blood IL-4 levels |
| Secondary | IL-4 | Visit 4 (180±3 days from baseline) | Blood IL-4 levels |
| Secondary | IFN-γ | Visit 1 (baseline) | Blood IFN-γ levels |
| Secondary | IFN-γ | Visit 4 (180±3 days from baseline) | Blood IFN-γ levels |
| Secondary | SCFA | Visit 1 (baseline) | Faecal SCFA levels |
| Secondary | SCFA | Visit 2 (5±1 days from baseline) | Faecal SCFA levels |
| Secondary | SCFA | Visit 3 (90±3 days from baseline) | Faecal SCFA levels |
| Secondary | SCFA | Visit 4 (180±3 days from baseline) | Faecal SCFA levels |
| Secondary | Faecal microflora | Visit 1 (baseline) | Faecal microflora, including species phylogenetic analysis, Alpha diversity, and Beta diversity analysis. |
| Secondary | Faecal microflora | Visit 4 (180±3 days from baseline) | Faecal microflora, including species phylogenetic analysis, Alpha diversity, and Beta diversity analysis. |
| Secondary | sIgA | Visit 1 (baseline) | Salivary sIgA levels |
| Secondary | sIgA | Visit 2 (5±1 days from baseline) | Salivary sIgA levels |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07882043/registered